Join
Live feed
·
PRReleasevia Quantisnow
Talaris Therapeutics Inc. logo

Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio

ByQuantisnow·Wall Street's wire, on your screen.
TALS· Talaris Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TALS (Talaris Therapeutics Inc.) and more on Quantisnow.